Medical devices and methods of treatment are described herein. More particularly, medical devices and methods for providing access to a bodily passage during dilation are described herein. An exemplary medical device comprises an elongate member and a balloon. The elongate member is moveable between a first, non-expanded configuration and a second, expanded configuration.

Medical devices and methods of treatment are described herein. More particularly, medical devices and methods for providing access to a bodily passage during dilation are described herein. An exemplary medical device comprises an elongate member and a balloon. The elongate member is moveable between a first, non-expanded configuration and a second, expanded configuration.

A system for delivering a therapeutic agent to nasopharyngeal mucosa tissue has a shaft, a porous pad of compliant material coupled to the shaft near the distal end, and a drug reservoir. The porous pad is configured to expand from a contracted configuration to an expanded configuration. The expanded configuration is adapted to engage and conform to the mucosa tissue in a nasal cavity, and the contracted configuration has a size suitable for introduction into the nasal cavity. The drug reservoir holds a therapeutic agent and is at least partially covered by the porous pad. The drug reservoir is configured to release a fixed volume of the therapeutic agent into the porous pad within a period of less than about 120 minutes, and has a wall with a plurality of channels fluidly coupled with the porous pad.

A system for delivering a therapeutic agent to nasopharyngeal mucosa tissue has a shaft, a porous pad of compliant material coupled to the shaft near the distal end, and a drug reservoir. The porous pad is configured to expand from a contracted configuration to an expanded configuration. The expanded configuration is adapted to engage and conform to the mucosa tissue in a nasal cavity, and the contracted configuration has a size suitable for introduction into the nasal cavity. The drug reservoir holds a therapeutic agent and is at least partially covered by the porous pad. The drug reservoir is configured to release a fixed volume of the therapeutic agent into the porous pad within a period of less than about 120 minutes, and has a wall with a plurality of channels fluidly coupled with the porous pad.

A system for safely delivering an efficient amount of oxygen to essential organs, during cardiopulmonary resuscitation (CPR) is described; a respective method and an endotracheal device for delivering a semi-spontaneous positive-pressure ventilation are further described; the system comprises; at least one limb compression device, a positive-pressure ventilation system, an endotracheal tube, a cardiac stimulation device, an intra-tracheal pressure sensor, a synchronizer; the method comprises; compressing at least one limb device and occluding a blood flow into the limb, delivering a mixture of gases, providing an endotracheal tube, conferring a deployed configuration, conferring a withheld configuration, performing a cardiac stimulation device, determining a pressure, synchronizing a timing; the endotracheal device comprises; an elongated tube, a sealing cuff assuming a deployed configuration and withheld

A device for delivering a substance to an airway of a patient may include a laryngeal mask airway device, at least one substance delivery reservoir coupled with the laryngeal mask airway device for delivering the substance to the airway of the patient, and at least one conduit coupled with the laryngeal mask airway. The at least one conduit may have a proximal end configured to couple with a source of the substance residing outside the patient and a distal end in fluid communication with the at least one substance delivery reservoir.

In an embodiment, a tracheal tube system has a first tube, which is flexible. The tube has an opening that is located on the sidewalls. A balloon is attached to the flexible tube. When inflated, the balloon forms a second tube surrounding the first tube with an air space between the first wall of the balloon and the sidewalls of the first tube. The balloon extends covering the opening on the sidewall. Air flowing into the first tube exits, via the third opening into the airspace between the first tube and the balloon, out of the airspace. In another embodiment, the balloon has a tube with multiplicity of holes in the walls is wrapped around the outer wall of the balloon. Negative pressure in the third tube creates suction holding the outer wall of the balloon to walls of the trachea.

An apparatus treats tissue at or near a sphincter. The apparatus has an elongated member having at least one lumen including an inflation lumen, and a basket assembly including a first and a second arm. An inflatable member is coupled to the inflation lumen and has a deployed and a non-deployed state. In the deployed state, the inflatable member expands the basket assembly into contact with tissue. At least one of the first and second arms of the basket assembly has a fluid lumen having an aperture for conveying a fluid from the basket assembly. A source of fluid is coupled to the fluid lumen for conveyance of fluid through the aperture. The fluid can be, e.g., an electrolytic solution, and/or an anti-infection agent, and/or an echogenic media, and/or a steroid, and/or an anesthetic, and/or a medicament, and/or a tissue cooling agent. The source can be a drug delivery device.